Clinical Trial Update: The Jetstream (JET) Post-market Registry [Phase 4]

View source ↗

Summary

The Jetstream post-market registry for peripheral arterial disease has completed Phase 4 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Jetstream (JET) Post-market Registry

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Peripheral Arterial Diseases | Phase 4 | Status: COMPLETED | Results posted: 2016-08-26